Retreatment rates for uncomplicated gonorrhea infection: Comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline

Sexually Transmitted Diseases

Volumn 40, Issue 7, 2013, Pages 539-545

  Schumacher, Christina M ^a   Ghanem, Khalil G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; DOXYCYCLINE; ANTIINFECTIVE AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; OBSERVATIONAL STUDY; RECOMMENDED DRUG DOSE; RETREATMENT; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TIME TO TREATMENT; TREATMENT DURATION; COHORT ANALYSIS; DRUG COMBINATION; DRUG EFFECTS; MULTIVARIATE ANALYSIS; NEISSERIA GONORRHOEAE; SEXUALITY; SURVIVAL; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BALTIMORE; CEFTRIAXONE; COHORT STUDIES; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FEMALE; GONORRHEA; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEISSERIA GONORRHOEAE; RETREATMENT; RETROSPECTIVE STUDIES; SEXUAL PARTNERS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888644560     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182941325     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56: 332-336.
2. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
3. Yokoi S, Deguchi T, Ozawa T, et al. Threat to cefixime treatment for gonorrhea. Emerg Infect Dis 2007; 13:1275-1277.
4. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Eur Surveill 2010; 15:19721.
5. Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Eur Surveill 2011; 16:19833.
6. Unemo M, Golparian D, Stary A, et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Eur Surveill 2011; 16:19998.
7. Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012; 61: 590-594.
8. Centers for Disease Control and Prevention (CDC). Cephalosporin susceptibility among Neisseria gonorrhoeae isolatesVUnited States, 2000-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 873-877.
9. Blasnik M. Reclink. 2010. http://fmwww.bc.edu/repec/bocode/r/reclink/ado.
10. Mehta SD, Erbelding EJ, Zenilman JM, et al. Gonorrhoea reinfection in heterosexual STD clinic attendees: Longitudinal analysis of risks for first reinfection. Sex Transm Infect 2003; 79:124-128.
11. Ota KV, Fisman DN, Tamari IE, et al. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: A 13-year retrospective cohort study. Clin Infect Dis 2009; 48:1237-1243.
12. De P, Singh AE, Wong T, et al. Predictors of gonorrhea reinfection in a cohort of sexually transmitted disease patients in Alberta, Canada, 1991-2003. Sex Transm Dis 2007; 34:30-36.
13. Fung M, Scott KC, Kent CK, et al. Chlamydial and gonococcal reinfection among men: A systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007; 83:304-309.
14. Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhea among females: A systematic review of the literature. Sex Transm Dis 2009; 36:478-489.
15. Baltimore City Health Department Sexually Transmitted Disease Clinics. Expedited partner therapy for partners of patients with gonorrhea or chlamydia: 2011 report for pilot program activities. Available at: dlslibrary.state.md.us/ publications/Baltimore/HG18-214. 1(f )-2011.pdf.
16. Shiely F, Hayes K, Thomas KK, et al. Expedited partner therapy: A robust intervention. Sex Transm Dis 2010; 37:602-607.
17. Stephens SC, Bernstein KT, Katz MH, et al. The effectiveness of patient-delivered partner therapy and chlamydial and gonococcal reinfection in San Francisco. Sex Transm Dis 2010; 37:525-529.
18. Centers for Disease Control and Prevention (CDC). GISP profile, 2010. 2012.
19. Centers for Disease Control and Prevention (CDC). Cephalosporin- Resistant Neisseria gonorrhoeae Public health response plan. 2012.